Long-Term Outcomes Stratified by Body Mass Index in Patients Undergoing Transcatheter Aortic Valve Implantation.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 12 2020
Historique:
received: 01 07 2020
revised: 22 09 2020
accepted: 23 09 2020
pubmed: 6 10 2020
medline: 23 12 2020
entrez: 5 10 2020
Statut: ppublish

Résumé

Transcatheter aortic valve implantation (TAVI) is emerging as the default strategy for older patients with severe, symptomatic, and trileaflet aortic stenosis. Increased body-mass index (BMI) is associated with a protective effect in patients undergoing percutaneous coronary intervention. We assessed whether elevated BMI was associated with a similar association in TAVI. We evaluated prospectively collected data from 634 patients who underwent TAVI at 2 centers from August 2008 to April 2019. Patients were stratified as normal weight (BMI 18.5 to 24.9 kg/m

Identifiants

pubmed: 33017578
pii: S0002-9149(20)31014-6
doi: 10.1016/j.amjcard.2020.09.039
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-82

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Edward J Quine (EJ)

Department of Cardiology, Alfred Health, Melbourne, Australia.

Misha Dagan (M)

Department of Cardiology, Alfred Health, Melbourne, Australia.

Jeremy William (J)

Department of Cardiology, Alfred Health, Melbourne, Australia.

Shane Nanayakkara (S)

Department of Cardiology, Alfred Health, Melbourne, Australia; Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne, Australia.

Luke P Dawson (LP)

Department of Cardiology, Royal Melbourne Hospital, Victoria, Australia.

Stephen J Duffy (SJ)

Department of Cardiology, Alfred Health, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

Julia Stehli (J)

Department of Cardiology, Alfred Health, Melbourne, Australia; Department of Cardiology, Epworth Hospital, Melbourne, Australia.

Ron J Dick (RJ)

Department of Cardiology, Epworth Hospital, Melbourne, Australia.

Nay M Htun (NM)

Department of Cardiology, Alfred Health, Melbourne, Australia.

Dion Stub (D)

Department of Cardiology, Alfred Health, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

Antony S Walton (AS)

Department of Cardiology, Alfred Health, Melbourne, Australia; Department of Cardiology, Epworth Hospital, Melbourne, Australia. Electronic address: twalton93@me.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH